Prostatic Hypertrophy, Benign Completed Phase 2 Trials for Degarelix (DB06699)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00527488Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.Treatment